Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip B Mitchell

Showing results (221-230 of 315) with videos related to

Pageof 32
Sort By:
The British Journal of Psychiatry : the Journal of Mental Science|March 31, 2026
Effect of ketamine on anxiety: findings from the Ketamine for Adult Depression Study - RETRACTIONNatalie T Mills, Stevan Nikolin, Nick Glozier, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|November 28, 2017
Traumatic Stress Interacts With Bipolar Disorder Genetic Risk to Increase Risk for Suicide AttemptsHolly C Wilcox, Janice M Fullerton, Anne L Glowinski, et al.
Journal of Affective Disorders|May 29, 2025
Economic evaluation of subcutaneous ketamine injections for treatment resistant depression: A randomised, double-blind, active-controlled trial - The KADS studyMary Lou Chatterton, Johana Kevin Perez, Thao Thai, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|December 8, 2020
A clinical approach to treatment resistance in depressed patients: What to do when the usual treatments don't work well enough?Seetal Dodd, Michael Bauer, Andre F Carvalho, et al.
Molecular Neurobiology|December 6, 2015
Convergent Lines of Evidence Support LRP8 as a Susceptibility Gene for PsychosisMing Li, Liang Huang, Maria Grigoroiu-Serbanescu, et al.
Molecular Neurobiology|August 27, 2016
Identification of a Bipolar Disorder Vulnerable Gene CHDH at 3p21.1Hong Chang, Lingyi Li, Tao Peng, et al.
Molecular Psychiatry|May 21, 2026
White matter microstructure in relatives of people with schizophrenia or bipolar disorder: an ENIGMA meta-analysisMarjolein E A Barendse, Simon R Poortman, Christopher R K Ching, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|May 20, 2026
The American Society of Clinical Psychopharmacology task force consensus statement on the deprescribing of stimulant medications in adults with ADHD<sup>✰</sup>David W Goodman, Rajnish Mago, Leslie Citrome, et al.
JAMA Network Open|April 16, 2025
Polygenic Scores and Mood Disorder Onsets in the Context of Family History and Early PsychopathologyKathryn Freeman, Alyson Zwicker, Janice M Fullerton, et al.
Translational Psychiatry|December 12, 2017
Common variants at 2q11.2, 8q21.3, and 11q13.2 are associated with major mood disordersXiao Xiao, Lu Wang, Chuang Wang, et al.
Pageof 32

Showing results (221-230 of 315) with videos related to

Sort By:
Pageof 32
The British Journal of Psychiatry : the Journal of Mental Science|March 31, 2026
Effect of ketamine on anxiety: findings from the Ketamine for Adult Depression Study - RETRACTIONNatalie T Mills, Stevan Nikolin, Nick Glozier, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|November 28, 2017
Traumatic Stress Interacts With Bipolar Disorder Genetic Risk to Increase Risk for Suicide AttemptsHolly C Wilcox, Janice M Fullerton, Anne L Glowinski, et al.
Journal of Affective Disorders|May 29, 2025
Economic evaluation of subcutaneous ketamine injections for treatment resistant depression: A randomised, double-blind, active-controlled trial - The KADS studyMary Lou Chatterton, Johana Kevin Perez, Thao Thai, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|December 8, 2020
A clinical approach to treatment resistance in depressed patients: What to do when the usual treatments don't work well enough?Seetal Dodd, Michael Bauer, Andre F Carvalho, et al.
Molecular Neurobiology|December 6, 2015
Convergent Lines of Evidence Support LRP8 as a Susceptibility Gene for PsychosisMing Li, Liang Huang, Maria Grigoroiu-Serbanescu, et al.
Molecular Neurobiology|August 27, 2016
Identification of a Bipolar Disorder Vulnerable Gene CHDH at 3p21.1Hong Chang, Lingyi Li, Tao Peng, et al.
Molecular Psychiatry|May 21, 2026
White matter microstructure in relatives of people with schizophrenia or bipolar disorder: an ENIGMA meta-analysisMarjolein E A Barendse, Simon R Poortman, Christopher R K Ching, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|May 20, 2026
The American Society of Clinical Psychopharmacology task force consensus statement on the deprescribing of stimulant medications in adults with ADHD<sup>✰</sup>David W Goodman, Rajnish Mago, Leslie Citrome, et al.
JAMA Network Open|April 16, 2025
Polygenic Scores and Mood Disorder Onsets in the Context of Family History and Early PsychopathologyKathryn Freeman, Alyson Zwicker, Janice M Fullerton, et al.
Translational Psychiatry|December 12, 2017
Common variants at 2q11.2, 8q21.3, and 11q13.2 are associated with major mood disordersXiao Xiao, Lu Wang, Chuang Wang, et al.
Pageof 32